1-3 of 3
Dominique Derreumaux
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dasatinib In Children and Adolescents with Relapsed or Refractory Leukemia: Results of the CA180018 Phase 1 Dose-Escalation Study of the Innovative Therapies for Children with Cancer (ITCC) Consortium

C. Michel Zwaan, Carmelo Rizzari, Francoise Mechinaud, Donna L Lancaster, MBChB, MRCPCH, Pamela R. Kearns, BSc, MBBCh, MRCP, PhD, Thomas Lehrnbecher, Vincent H. J. van der elden, H. Berna Beverloo, PhD, Monique L. den Boer, Rob Pieters, MD, PhD, Julie Rosenberg, Robert Herdlicka, Dominique Derreumaux, Shruti Agrawal, AndreĢ Baruchel
Journal: Blood
Blood (2010) 116 (21): 2265.
https://doi.org/10.1182/blood.V116.21.2265.2265
Published: 2010
Journal Articles

Dasatinib in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: Preliminary Results of a Phase I Study.

Thierry Facon, Xavier Leleu, A. Keith Stewart, MD, Andrew Spencer, Philip Rowlings, Cyrille Hulin, Michel Attal, Felix Garzon, MD, PhD, Eric Bleickardt, Konstantina Gialelis, Doreen Tuozzoli, Dominique Derreumaux, Pieter Sonneveld
Journal: Blood
Blood (2009) 114 (22): 1876.
https://doi.org/10.1182/blood.V114.22.1876.1876
Published: 2009
Journal Articles

Dasatinib in Children and Adolescents with Relapsed or Refractory Leukemia: Interim Results of the CA180-018 Phase I Study from the ITCC Consortium.

C. Michel Zwaan, MD, PhD, Carmelo Rizzari, Vincent H.J. van der Velden, Berna Beverloo, M. L. den Boer, Andre Baruchel, Francoise Mechinaud, Donna Lancaster, Yousif Matloub, Dominique Derreumaux, Rob Pieters, Pamela Kearns
Journal: Blood
Blood (2008) 112 (11): 3241.
https://doi.org/10.1182/blood.V112.11.3241.3241
Published: 2008